AUTH/2691/1/14: Member of the public v Otsuka (Clinical trial disclosure – Cimiza) – No breach (outwith scope) | PMCPA Case

📊

Key facts

⌄

Case number	AUTH/2691/1/14
Complainant	Member of the public
Company	Otsuka
Issue	Clinical trial disclosure (Cimiza)
Complaint received	02 January 2014
Completed	20 March 2014
Outcome	No breach, outwith the scope of the Code
Clauses cited	Not stated
Sanctions	None stated
Case report	No case report (outwith the scope of the Code)

Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI

🎬 Expert Video Walkthrough

🎬

Video walkthrough — coming for members

Subscribe now and get expert video analysis for every case as we publish them.

Subscribe — from £299/yr

📋

⌄

A member of the public made a complaint to the PMCPA about clinical trial disclosure relating to Cimiza.
The PMCPA determined the matter was outwith the scope of the ABPI Code of Practice.

⚖️

⌄

🔒

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value

£249/year

Annual — save £99

£29/mo

Monthly

Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →